Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Papa Johns International | PZZA | Jan 15, 2025 | 36.85 | -2.31 |
Papaya Growth Opportunity I SPAC A | PPYA | Jan 15, 2025 | 11.51 | +0.88 |
Papaya Growth Opportunity I Unit | PPYAU | Jan 15, 2025 | 11.10 | -1.77 |
Par Pacific | PARR | Jan 15, 2025 | 18.40 | +2.39 |
PAR Technology | PAR | Jan 15, 2025 | 76.00 | +5.86 |
Paragon 28 | FNA | Jan 15, 2025 | 10.25 | -0.29 |
Paramount Global A | PARAA | Jan 15, 2025 | 22.52 | -0.18 |
Paramount Global B | PARA | Jan 15, 2025 | 10.44 | -2.16 |
Paramount Gold Nevada | PZG | Jan 15, 2025 | 0.36 | -1.15 |
Paramount Group | PGRE | Jan 15, 2025 | 4.61 | +2.67 |
Paranovus Entertainment Technology A | PAVS | Jan 15, 2025 | 1.34 | -0.98 |
ParaZero Technologies | PRZO | Jan 15, 2025 | 1.85 | -2.63 |
Park Aerospace | PKE | Jan 15, 2025 | 14.45 | +1.55 |
Park Hotels & Resorts | PK | Jan 15, 2025 | 13.80 | +0.66 |
Park National | PRK | Jan 15, 2025 | 170.54 | -1.03 |
Park-Ohio | PKOH | Jan 15, 2025 | 25.15 | +1.58 |
Parke Bancorp | PKBK | Jan 15, 2025 | 19.82 | +1.17 |
Parker-Hannifin | PH | Jan 15, 2025 | 656.32 | +1.44 |
Parsons | PSN | Jan 15, 2025 | 95.39 | +0.97 |
Pasithea Therapeutics | KTTA | Jan 15, 2025 | 2.46 | -2.57 |
Passage Bio | PASG | Jan 15, 2025 | 0.59 | -1.99 |
Pathfinder Bancorp | PBHC | Jan 15, 2025 | 15.81 | +2.80 |
Pathward Financial | CASH | Jan 15, 2025 | 77.27 | +2.10 |
Patria Investments A | PAX | Jan 15, 2025 | 11.51 | +2.31 |
Patria Latin American Opportunity Acquisition A | PLAO | Jan 15, 2025 | 11.64 | 0.00 |
Patrick Industries | PATK | Jan 15, 2025 | 90.02 | +5.00 |
Patriot National Bancorp | PNBK | Jan 15, 2025 | 1.63 | -8.37 |
Patterson Companies | PDCO | Jan 15, 2025 | 30.89 | 0.00 |
Patterson-UTI Energy | PTEN | Jan 15, 2025 | 9.33 | +4.25 |
PAVmed | PAVM | Jan 15, 2025 | 0.65 | +8.35 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.